SVCT3 activators play a pivotal role in enhancing the function of solute carrier family 23 member 3, a transporter specifically involved in the cellular uptake of ascorbic acid. The activity of SVCT3 is directly influenced by the presence of its substrate, ascorbic acid, where an increased concentration of this vitamin facilitates the transporter's function by providing more substrate for transport. Additionally, the operation of SVCT3 is intrinsically linked to the sodium gradient across the cell membrane, and the presence of sodium ions is critical for its proper function, as this transporter relies on the electrochemical gradient to actively transport ascorbic acid into the cells. Furthermore, the transcription of SVCT3 can be upregulated by compounds that modulate gene expression related to antioxidant defense mechanisms, enhancing the cellular capacity to counteract oxidative stress by improving ascorbic acid uptake. Hormonal regulators, which promote the translocation of transporters to the cell membrane, also have the potential to increase the functional presence of SVCT3, thereby augmenting its activity.
Various signaling molecules and metabolic products are known to influence the expression and membrane localization of SVCT3, thereby indirectly promoting its activity. Compounds that activate protein kinase C, for instance, can modify the trafficking and function of membrane transporters, potentially leading to an increased activity of SVCT3 on the cell surface. Some hormones have been shown to regulate the expression of various transporters, suggesting their role in modulating SVCT3 activity as well. Moreover, factors that lead to epigenetic changes can result in the upregulation of transporter expression, including SVCT3, thereby indirectly enhancing its functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $45.00 | 5 | |
As SVCT3 is a transporter for ascorbic acid, direct supplementation with this vitamin enhances the transporter's activity by serving as its substrate. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can activate gene expression related to vitamin C transporters. Increased transcription of SVCT3 enhances the availability of transporters and thus the capacity for ascorbic acid uptake. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
This compound activates protein kinase C which can modulate the trafficking and function of membrane transporters including SVCT3, thus potentially increasing its activity at the cell surface. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin can enhance the translocation of glucose transporters to the cell membrane and may have a similar effect on SVCT3, increasing its functional presence on the cell surface. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
Can regulate the expression of a variety of transporters and may increase the activity of SVCT3 through estrogen-receptor mediated signaling pathways. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $31.00 | 3 | |
As a modulator of chloride channels, niflumic acid could influence the membrane potential and indirectly affect the activity of co-transporters such as SVCT3. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase increasing cAMP levels, which could lead to the upregulation of SVCT3 activity due to cAMP-dependent signaling pathways influencing transporter expression. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $63.00 $174.00 | ||
Through histone deacetylase inhibition, can lead to epigenetic changes that increase the expression of certain transporters, potentially including SVCT3. | ||||||